AI assistant
BIO-TECHNE Corp — Director's Dealing 2018
Aug 9, 2018
30718_dirs_2018-08-09_e98d0fcf-4cb7-4b3e-bca7-736a2ce9e87d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2018-08-07
Reporting Person: Kummeth Charles R. (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-08-07 | Common Stock | M | 13816.00 | $0.00 | Acquired | 90288.00 | Direct |
| 2018-08-07 | Common Stock | F | 6301.00 | $180.14 | Disposed | 83987.00 | Direct |
| 2018-08-07 | Common Stock | F | 1752.00 | $180.14 | Disposed | 82235.00 | Direct |
| 2018-08-08 | Common Stock | A | 11279.00 | $0.00 | Acquired | 93514.00 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-08-07 | Restricted Stock Units | $ | M | 13816.00 | Disposed | Common Stock (13816.00) | Direct | |
| 2018-08-07 | Restricted Stock Units | $ | D | 3467.00 | Disposed | Common Stock (3467.00) | Direct | |
| 2018-08-07 | Stock Options (Right to buy) | $108.49 | D | 23929.00 | Disposed | 2022-08-07 | Common Stock (23929.00) | Direct |
| 2018-08-08 | Restricted Stock Units | $ | A | 16918.00 | Acquired | Common Stock (16918.00) | Direct | |
| 2018-08-08 | Stock Options (Right to buy) | $177.32 | A | 60222.00 | Acquired | 2025-08-08 | Common Stock (60222.00) | Direct |
| 2018-08-08 | Stock Options (Right to buy) | $177.32 | A | 90334.00 | Acquired | 2025-08-08 | Common Stock (90334.00) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Restricted Stock Units | $ | Common Stock (24979.00) | 24979.00 | Direct | |
| Restricted Stock Units | $ | Common Stock (21291.00) | 21291.00 | Direct | |
| Stock Option (Right to Buy) | $108.49 | 2022-08-07 | Common Stock (79517.00) | 79517.00 | Direct |
| Stock Option (Right to Buy) | $106.59 | 2023-08-18 | Common Stock (102779.00) | 102779.00 | Direct |
| Stock Option (Right to Buy) | $106.59 | 2023-08-18 | Common Stock (154169.00) | 154169.00 | Direct |
| Stock Option (Right to Buy) | $86.25 | 2021-04-01 | Common Stock (46316.00) | 46316.00 | Direct |
| Stock Option (Right to Buy) | $67.46 | 2020-04-01 | Common Stock (65000.00) | 65000.00 | Direct |
| Stock Option (Right to Buy) | $67.46 | 2020-04-01 | Common Stock (50000.00) | 50000.00 | Direct |
| Stock Options (Right to buy) | $125.05 | 2024-08-09 | Common Stock (117342.00) | 117342.00 | Direct |
| Stock Options (Right to buy) | $125.05 | 2024-08-09 | Common Stock (78228.00) | 78228.00 | Direct |
| Stock Options (Right to buy) | $94.35 | 2021-08-12 | Common Stock (66849.00) | 66849.00 | Direct |
Footnotes
F1: Restrictions lapse as to 3,760 shares on 8/8/19 and 8/8/20 and as to 3,759 shares on 8/8/21
F2: Includes (i) 11,102 shares of restricted stock for which the risks of forfeiture will lapse with respect to 5,551 shares on each of August 18, 2018 and August 18, 2019; (ii) 14,194 shares of restricted stock for which the risks of forfeiture will lapse with respect to 4,731 shares on each of August 9, 2018 and August 9, 2019 and as to 4,732 shares on August 9, 2020; and (iii) 11,279 shares of restricted stock for which the risk of forfeiture will lapse as to 3,760 shares on August 8, 2019 and August 8, 2010 and as to 3,759 shares on August 8, 2021.
F3: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F4: On 8/7/2018, the Board of Directors authorized discretionary vesting for 13,816 performance RSUs. The remainder of the performance RSUs were forfeited.
F5: On 8/7/2018, the Board of Directors authorized discretionary vesting for 95,346 performance options. The remainder of the performance options were forfeited.
F6: Vests in full or in part on 8/8/2021 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F7: Vests 15,056 shares each on 8/8/2019, 8/8/2020, and 15,055 shares each on 8/8/2021, 8/8/2022.
F8: Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F9: Vests in full or in part on 8/9/2020 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F10: 19,879 shares vest on each of August 7, 2016, August 7, 2017 and August 7, 2018 and 19,880 shares vest on August 7, 2019.
F11: Vests 25,695 shares on each of 8/18/17, 8/18/18, and 8/18/19 and 25,694 shares on 8/18/20.
F12: Fully exercisable
F13: Vests 19,557 each on 8/9/2018, 8/9/2019, 8/9/2020, 8/9/2021